Kalvista Pharmaceuticals Inc. (KALV)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 1,824,000 $26,466 1.21%
2. 1,800,000 $26,118 3.2%
3. 1,707,100 $24,770 -12% 1.02%
4.
Great Point Partners

Jeffrey Jay And David Kroin

1,551,719 $22,515 +2% 5.42%
5.
Vivo Capital

Albert Cha And Frank Kung

1,533,559 $22,252 2.45%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.34 47,431 Director 1,138,179 2020-10-30 Filing
$17.17 68,255 Director 1,090,748 2020-10-30 Filing
$11.87 7,962 Director 10,000 2019-09-27 Filing
$11.90 2,038 Director 2,038 2019-09-26 Filing
$17.13 5,137 Director 124,566 2019-07-29 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$5.44 1,139 Officer 34,232 2022-11-18 Filing
$5.44 722 Officer 68,390 2022-11-18 Filing
$5.44 530 Officer 62,376 2022-11-18 Filing
$5.44 1,785 Officer, Director 114,878 2022-11-18 Filing
$5.44 722 Officer 5,946 2022-11-18 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 7,243 $105,096 0%
2. 1,706,148 $24,757 0%
3. 1,572,192 $22,813 1.75%
4. 1,158,385 $16,808 0%
5. 1,149,861 $16,684 0%
News See All